Bioextrax AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 0.052334 million. Revenue was SEK 0.334326 million compared to SEK 0.164069 million a year ago. Net loss was SEK 2.56 million compared to SEK 1.25 million a year ago. Basic loss per share from continuing operations was SEK 0.1735 compared to SEK 0.0986 a year ago. For the nine months, sales was SEK 0.092334 million compared to SEK 0.021776 million a year ago. Revenue was SEK 0.40061 million compared to SEK 0.221776 million a year ago. Net loss was SEK 7.63 million compared to SEK 3.63 million a year ago. Basic loss per share from continuing operations was SEK 0.5172 compared to SEK 0.2689 a year ago.